ERRα modulates estrogen responsiveness and substitutes for ER activities in breast cancer and was found to be critical for growth of ERα-negative breast cancer cells (Kraus et al. 2002; Liu et al. 2018; Stein and McDonnell 2006). The gene discussed is ESRRA; the disease is breast cancer.